Autolus Therapeutics' Q2 2026 saw a 74% sales jump to $45.7M and a gross margin expansion to 55%. I rate AUTL stock as Hold. Click to read my full analysis.
CryptoAlerta — análise de criptomoedas e mercado em tempo real